Lichenoid dermatitis in three patients with metastatic melanoma treated with anti-PD-1 therapy

Cancer Immunology Research

Volumn 3, Issue 1, 2015, Pages 18-22

  Joseph, Richard W ^a   Cappel, Mark ^a   Goedjen, Brent ^a   Gordon, Matthew ^a   Kirsch, Brandon ^a   Gilstrap, Cheryl ^a   Bagaria, Sanjay ^a   Jambusaria Pahlajani, Anokhi ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; DEXAMETHASONE; FLUORODEOXYGLUCOSE F 18; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IPILIMUMAB; LISINOPRIL; PEMBROLIZUMAB; PROGRAMMED DEATH 1 LIGAND 1; STEROID; TEMOZOLOMIDE; TRIAMCINOLONE; MONOCLONAL ANTIBODY; PROGRAMMED DEATH 1 RECEPTOR;

ADRENAL METASTASIS; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN METASTASIS; CANCER ADJUVANT THERAPY; CANCER STAGING; CASE REPORT; CD4+ T LYMPHOCYTE; COLITIS; COMPASSIONATE USE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DERMATITIS; DIFFERENTIAL DIAGNOSIS; DRUG TOLERABILITY; DRUG WITHDRAWAL; EOSINOPHIL COUNT; ERYTHEMA; ERYTHEMATOSQUAMOUS SKIN DISEASE; FEMALE; GENE MUTATION; HUMAN; HYPERKERATOSIS; IMMUNOHISTOCHEMISTRY; LICHEN PLANUS; LICHENOID ERUPTION; LUNG LESION; LUNG METASTASIS; LUNG NODULE; LYMPHOCYTIC INFILTRATION; MALE; METASTATIC MELANOMA; MIDDLE AGED; MITOSIS RATE; MULTIPLE CYCLE TREATMENT; MUTATIONAL ANALYSIS; PAPULAR RASH; PAPULE; PAROTIDECTOMY; PHASE 1 CLINICAL TRIAL (TOPIC); PRURITUS; PSORIASIS; PUNCH BIOPSY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; SENTINEL LYMPH NODE BIOPSY; SKIN BIOPSY; STEREOTACTIC BODY RADIATION THERAPY; T LYMPHOCYTE; TREATMENT REFUSAL; TREATMENT RESPONSE; TUMOR VOLUME; VERY ELDERLY; WIDE EXCISION; CHEMICALLY INDUCED; DRUG ERUPTION; IMMUNOLOGY; MELANOMA; PATHOLOGY; SECONDARY;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIGENS, CD274; DRUG ERUPTIONS; EXANTHEMA; FEMALE; HUMANS; LICHENOID ERUPTIONS; MALE; MELANOMA; MIDDLE AGED; PROGRAMMED CELL DEATH 1 RECEPTOR; PRURITUS; T-LYMPHOCYTES;

EID: 84939470051     PISSN: 23266066     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-14-0134     Document Type: Article

References (12)

1. Hamid O, Robert C, Daud A., Hodi FS, Hwu WJ, Kefford R, et al Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med 2013;369:134-44.
2. Brahmer JR, Tykodi SS, Chow L.Q., Hwu WJ, Topalian SL, Hwu P, et al Safety and activity of Anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 2012;366:2455-65.
3. Topalian SL, Hodi FS, Brahmer J.R., Gettinger SN, Smith DC, McDermott DF, et al Safety, activity, and immune correlates of Anti-PD-1 antibody in cancer. N Engl J Med 2012;366:2443-54.
4. Robert C, Ribas A, Wolchok J.D., Hodi FS, Hamid O, Kefford R, et al Anti programmed-death-receptor-1treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial. Lancet 2014;384:1109-17.
5. Hodi FS, O'Day SJ, McDermott DF, Weber R.W., Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363:711-23.
6. Wolchok JD, Weber JS, Maio M, Neyns B., Harmankaya K, Chin K, et al Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials. Ann Oncol 2013;24: 2174-80.
7. Minkis K, Garden BC, Wu S, Pulitzer M.P., Lacouture ME. The risk of rash associated with ipilimumab in patients with cancer: A systematic review of the literature and meta-analysis. J Am Acad Dermatol 2013;69:e121-8.
8. Weber JS, Kahler KC, Hauschild A. Management of immune-related adverse events and kinetics of response with ipilimumab. J Clin Oncol 2012;30:2691-7.
9. Steward M, Bishop R, Piggott N.H., Milton ID, Angus B, Horne CH. Production and characterization of a new monoclonal antibody effective in recognizing the CD3 T-cell associated antigen in formalin-fixed embedded tissue. Histopathology 1997;30:16-22.
10. Reinherz EL, Kung PC, Goldstein G, Schlossman SF Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci U S A 1979;76:4061-5.
11. Liarski VM, Kaverina N, Chang A., Brandt D, Yanez D, Talasnik L., et al. Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue. Sci Transl Med 2014;6:230ra46.
12. Sontheimer RD. Lichenoid tissue reaction/interface dermatitis: clinical and histological perspectives. J Invest Dermatol 2009;129:1088-99.